发明名称 Pharmaceutical compositions providing enhanced drug concentrations
摘要 A drug in a solubility-improved form is combined with a concentration-enhancing polymer in a sufficient amount so that the combination provides substantially enhanced drug concentration in a use environment relative to a control comprising the same amount of the same solubility-improved form of drug without the concentration-enhancing polymer.
申请公布号 US9457095(B2) 申请公布日期 2016.10.04
申请号 US201514659271 申请日期 2015.03.16
申请人 Bend Research, Inc. 发明人 Curatolo William J.;Shanker Ravi M.;Babcock Walter C.;Friesen Dwayne T.;Nightingale James A. S.;Lorenz Douglas A.
分类号 A61K47/38;A61K9/14;A61K9/16;A61K31/135;A61K31/4375;A61K31/4178;A61K31/496;A61K31/517;A61K31/404 主分类号 A61K47/38
代理机构 Klarquist Sparkman, LLP 代理人 Klarquist Sparkman, LLP
主权项 1. A composition comprising: (a) a drug in a pharmaceutically acceptable form that is a crystalline highly soluble salt form other than the crystalline hydrochloride salt, wherein the crystalline highly soluble salt form has an aqueous solubility at least 1.25-fold the aqueous solubility of the more soluble of the crystalline free base and the crystalline hydrochloride salt forms of the drug; and (b) a concentration-enhancing polymer,wherein said drug alone has an aqueous solubility of up to 2 mg/mL at pH 1 to 8; and said composition is not a molecular dispersion.
地址 Bend OR US